Mosaic Surgical Launches New Fixed Fee Service to Support Post-Brexit UKCA Marking

February 11, 2021

Mosaic Surgical Ltd is based in High Wycombe, UK.

Today the company announced a new fixed-fee service for UKCA marking with a UK notified body that will support manufacturers and distributors of surgical products that previously traded under EU law and CE marking before Brexit, and help to ensure continuity of production, conformity with sales legislation and, crucially, uninterrupted trade in the UK.

New legislation for marketing products in the UK came into force on January the 1st 2021, stipulating that most goods previously subject to the CE marking must now comply with and display UKCA marking instead.

The County Mayo-based company Idoman Teoranta was the first to recognise the value of Mosaic Surgical’s newly launched service, and has already entered into an agreement to deliver UKCA marking for its Thermablate EAS™, a handheld automated device for treatment of heavy menstrual bleeding.

Manufactured by Idoman and distributed by JUNE Medical, Thermablate EAS offers fast, safe and effective ablation treatment in just three minutes. Under the agreement, Mosaic Surgical will assume the role of the UK Responsible Person, providing a cost-effective route to UKCA marking. Other well-known companies that have also engaged Mosaic Surgical as their UK representative include Synergo Medical and Neomedic.

Emma Maidwell, Managing Director of JUNE Medical, commented: “As the distributor for Thermablate EAS, we are delighted to see that Mosaic Surgical, a reputable and knowledgeable company, is to become the UK Responsible Person for this product, smoothing the transition to UKCA marking.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version